Arbor Pharmaceuticals, Inc.
About Arbor Pharmaceuticals
Unique Brands for Pediatrics
Arbor Pharmaceuticals is dedicated to introducing and growing unique pharmaceutical brands that have features closely aligned with those desired by pediatricians and their patients. Specifically, Arbor will initially focus on acute care medicines that incorporate well characterized (safe and effective) molecules with novel delivery systems to enhance the product profile.
The company’s unique business model and strategic focus will enable Arbor to build a leadership position within the growing pediatric pharmaceutical market. Arbor will leverage its established relationships with pharmaceutical development and commercialization partners to develop and deliver improved medicines to pediatricians throughout the United States.
The Arbor leadership team has decades of experience in the pharmaceutical industry focused on identifying market needs and commercializing unique brands. Through its deep network of industry partners, Arbor is poised to rapidly introduce novel treatments that will enhance the treatment of the most common pediatric illnesses.
Arbor Pharmaceuticals Leadership
Jarrett T. Disbrow, President & Chief Executive Officer
Mr. Disbrow brings over a decade of experience in the pharmaceutical industry focused on successful product commercialization. Prior to founding Arbor in April 2006, he served as the head of marketing for TEAMM Pharmaceuticals, a division of Accentia BioPharmaceuticals. While at TEAMM, Jarrett was responsible for the launch and marketing of several key products in addition to helping to build the company’s product pipeline. With TEAMM, he was a member of the senior management team and directly involved in all areas of commercialization. Mr. Disbrow began his career with GlaxoSmithKline where he held roles of increasing responsibility in sales & marketing including being a part of the Advair® brand marketing team.
Josh Disbrow, Vice President of Commercial Operations
Mr. Disbrow has spent over 10 years in the pharmaceutical, diagnostic, and medical device industries and has held positions of increasing responsibility in sales, marketing, sales management, commercial operations, and strategy. Most recently he held a sales management position with Cyberonics, Inc., a medical device company focused on neuromodulation therapies. Prior to joining Cyberonics, Josh served as Director of Marketing at LipoScience, Inc., a specialty cardiovascular diagnostics company and oversaw commercialization of the company’s lead product. Prior to that, he held positions of increasing responsibility within sales and marketing at GlaxoSmithKline and Amgen. Josh received an MBA from the Babcock School of Management at Wake Forest University.
John Donofrio, Vice President of Operations and Controller
Mr. Donofrio has over 30 years of experience in the pharmaceutical and healthcare industry with emphasis on operations and finance. John spent the majority of his career in various Senior-level financial positions with Pilling Weck Inc. (formerly Edward Weck Inc., a division of Bristol-Myers Squibb), including Controller and Chief Financial Officer. Prior to joining Arbor, he served in financial roles with Fresenius Kabi (formerly a division of Pharmacia & Upjohn). Mr. Donofrio has deep experience in all areas of financial management including corporate mergers, acquisitions and divestiture, cost-system design and implementation and international reporting.
Arbor has also assembled a deep network of industry partners to support product development and commercialization.
